vs
Side-by-side financial comparison of NORTECH SYSTEMS INC (NSYS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $30.3M, roughly 1.1× NORTECH SYSTEMS INC). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -28.1%, a 31.0% gap on every dollar of revenue. On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -18.9%). NORTECH SYSTEMS INC produced more free cash flow last quarter ($5.5M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -5.9%).
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
NSYS vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $32.6M |
| Net Profit | $897.0K | $-9.2M |
| Gross Margin | 16.7% | 77.5% |
| Operating Margin | 3.0% | -34.8% |
| Net Margin | 3.0% | -28.1% |
| Revenue YoY | 5.9% | -18.9% |
| Net Profit YoY | 160.7% | -54.1% |
| EPS (diluted) | $0.32 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $32.6M | ||
| Q3 25 | $30.5M | $30.3M | ||
| Q2 25 | $30.7M | $33.6M | ||
| Q1 25 | $26.9M | $37.9M | ||
| Q4 24 | $28.6M | $40.2M | ||
| Q3 24 | $31.4M | $35.3M | ||
| Q2 24 | $33.9M | $34.9M | ||
| Q1 24 | $34.2M | $29.5M |
| Q4 25 | $897.0K | $-9.2M | ||
| Q3 25 | $-146.0K | $-9.8M | ||
| Q2 25 | $313.0K | $-11.8M | ||
| Q1 25 | $-1.3M | $-8.2M | ||
| Q4 24 | $-1.5M | $-5.9M | ||
| Q3 24 | $-739.0K | $-6.3M | ||
| Q2 24 | $157.0K | $-6.1M | ||
| Q1 24 | $765.0K | $-9.1M |
| Q4 25 | 16.7% | 77.5% | ||
| Q3 25 | 16.5% | 79.9% | ||
| Q2 25 | 15.8% | 74.9% | ||
| Q1 25 | 11.4% | 74.8% | ||
| Q4 24 | 9.9% | 71.6% | ||
| Q3 24 | 12.2% | 71.4% | ||
| Q2 24 | 13.6% | 69.5% | ||
| Q1 24 | 15.9% | 70.1% |
| Q4 25 | 3.0% | -34.8% | ||
| Q3 25 | 3.1% | -40.1% | ||
| Q2 25 | 2.4% | -41.6% | ||
| Q1 25 | -6.0% | -28.2% | ||
| Q4 24 | -4.3% | -21.5% | ||
| Q3 24 | -1.5% | -26.1% | ||
| Q2 24 | 1.0% | -23.9% | ||
| Q1 24 | 3.4% | -36.2% |
| Q4 25 | 3.0% | -28.1% | ||
| Q3 25 | -0.5% | -32.4% | ||
| Q2 25 | 1.0% | -35.0% | ||
| Q1 25 | -4.9% | -21.6% | ||
| Q4 24 | -5.2% | -14.8% | ||
| Q3 24 | -2.4% | -17.9% | ||
| Q2 24 | 0.5% | -17.4% | ||
| Q1 24 | 2.2% | -30.8% |
| Q4 25 | $0.32 | $-0.22 | ||
| Q3 25 | $-0.05 | $-0.24 | ||
| Q2 25 | $0.12 | $-0.29 | ||
| Q1 25 | $-0.48 | $-0.20 | ||
| Q4 24 | $-0.51 | $-0.14 | ||
| Q3 24 | $-0.27 | $-0.16 | ||
| Q2 24 | $0.05 | $-0.16 | ||
| Q1 24 | $0.26 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $34.5M | $275.7M |
| Total Assets | $71.9M | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $228.1M | ||
| Q3 25 | $1.3M | $227.5M | ||
| Q2 25 | $652.0K | $227.5M | ||
| Q1 25 | $1.2M | $229.3M | ||
| Q4 24 | $916.0K | $237.2M | ||
| Q3 24 | $1.2M | $237.1M | ||
| Q2 24 | $1.5M | $233.3M | ||
| Q1 24 | $4.0M | $125.4M |
| Q4 25 | $34.5M | $275.7M | ||
| Q3 25 | $33.4M | $276.0M | ||
| Q2 25 | $33.4M | $278.0M | ||
| Q1 25 | $32.8M | $279.3M | ||
| Q4 24 | $34.0M | $281.2M | ||
| Q3 24 | $35.7M | $277.3M | ||
| Q2 24 | $36.1M | $275.2M | ||
| Q1 24 | $36.0M | $163.9M |
| Q4 25 | $71.9M | $311.8M | ||
| Q3 25 | $74.8M | $308.5M | ||
| Q2 25 | $74.8M | $309.0M | ||
| Q1 25 | $73.5M | $313.0M | ||
| Q4 24 | $72.4M | $318.6M | ||
| Q3 24 | $77.0M | $310.5M | ||
| Q2 24 | $76.3M | $305.5M | ||
| Q1 24 | $75.5M | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.6M | $-1.1M |
| Free Cash FlowOCF − Capex | $5.5M | $-2.3M |
| FCF MarginFCF / Revenue | 18.0% | -6.9% |
| Capex IntensityCapex / Revenue | 0.5% | 3.5% |
| Cash ConversionOCF / Net Profit | 6.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $-1.1M | ||
| Q3 25 | $-92.0K | $-1.2M | ||
| Q2 25 | $157.0K | $-4.4M | ||
| Q1 25 | $-2.9M | $-8.8M | ||
| Q4 24 | $793.0K | $-4.3M | ||
| Q3 24 | $-1.6M | $650.0K | ||
| Q2 24 | $-4.3M | $-4.0M | ||
| Q1 24 | $2.8M | $-9.3M |
| Q4 25 | $5.5M | $-2.3M | ||
| Q3 25 | $-242.0K | $-1.8M | ||
| Q2 25 | $58.0K | $-5.9M | ||
| Q1 25 | $-3.2M | $-9.4M | ||
| Q4 24 | $503.0K | $-5.1M | ||
| Q3 24 | $-1.6M | $-453.0K | ||
| Q2 24 | $-4.6M | $-5.5M | ||
| Q1 24 | $2.1M | $-11.3M |
| Q4 25 | 18.0% | -6.9% | ||
| Q3 25 | -0.8% | -5.8% | ||
| Q2 25 | 0.2% | -17.6% | ||
| Q1 25 | -11.9% | -24.8% | ||
| Q4 24 | 1.8% | -12.7% | ||
| Q3 24 | -5.2% | -1.3% | ||
| Q2 24 | -13.5% | -15.9% | ||
| Q1 24 | 6.1% | -38.2% |
| Q4 25 | 0.5% | 3.5% | ||
| Q3 25 | 0.5% | 1.9% | ||
| Q2 25 | 0.3% | 4.6% | ||
| Q1 25 | 1.0% | 1.5% | ||
| Q4 24 | 1.0% | 2.1% | ||
| Q3 24 | 0.1% | 3.1% | ||
| Q2 24 | 0.8% | 4.4% | ||
| Q1 24 | 2.2% | 6.7% |
| Q4 25 | 6.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.30× | — | ||
| Q1 24 | 3.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
